Last updated on November 2019

A Study Comparing the Combination of Nivolumab and Ipilimumab Versus Placebo in Participants With Localized Renal Cell Carcinoma


Find a site near you

Start Over

Local Institution

Yamagata-shi, Japan
5.34miles
  Connect »